Gastroenterology Search
Gastroenterology Gastroenterology

Conference Reports

Digital International Liver Congress™ 2020

27 August 2020 - 29 August 2020

ESMO World Congress on Gastrointestinal Cancer 2020 Virtual (ESMO GI 2020)

01 July 2020 - 04 July 2020

Digestive Disease Week 2020 (DDW 2020)

Chicago, Illinois, US
02 May 2020 - 05 May 2020

Crohn's & Colitis Congress 2020

Austin, Texas, US
23 January 2020 - 25 January 2020

European Society for Medical Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer (WCGC)

Barcelona
03 July 2019 - 06 July 2019

The International Liver Congress™ 2019 (ILC 2019)

Vienna, Austria
10 April 2019 - 14 April 2019

Advances in Inflammatory Bowel Diseases (AIBD 2018)

Orlando, Florida, US
13 December 2018 - 15 December 2018

Crohn's & Colitis Congress 2018

Las Vegas, Nevada
18 January 2018 - 20 January 2018

2018 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium

San Francisco, California, US
18 January 2018 - 20 January 2018
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Moderate coffee drinking could save lives from liver disease
Jairia Dela Cruz, 05 Oct 2020
Drinking more than two cups of coffee per day may just be the intervention that prevents hundreds of thousands of liver disease‐related deaths globally, a study reports.
How to control asthma well: Experts’ perspectives
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Once-weekly insulin as good as once-daily dose?
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.

Corticosteroids do not avert mortality in severe, critical COVID-19 patients
Stephen Padilla, Yesterday
Use of systemic corticosteroids does not reduce in-hospital mortality for patients with severe or critical coronavirus disease (COVID-19), which is in stark contrast to that observed in the RECOVERY clinical trial, according to a study in Wuhan, China.